Tag: Menarini Group

Menarini’s EMERALD study of ORSERDU in breast cancer shows promising results

businessnewstoday- December 9, 2023

The Menarini Group and its subsidiary, Stemline Therapeutics, Inc., have made a significant stride in breast cancer treatment with new findings from the pivotal EMERALD ... Read More

Menarini’s ORSERDU gets CHMP positive opinion in advanced breast cancer

businessnewstoday- July 22, 2023

The Menarini Group and its subsidiary, Stemline Therapeutics Inc., have received a favorable opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for ... Read More

FDA approves Guardant360 CDx assay as companion diagnostic for Menarini’s ORSERDU for metastatic breast cancer

Raghuram Kadari- February 1, 2023

Guardant Health, an oncology company, has secured the approval of the US Food and Drug Administration (FDA) for the company’s Guardant360 CDx liquid biopsy assay ... Read More

Glenmark gets marketing approval for Ryaltris in 13 European countries

pallavi123- September 30, 2021

Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and ... Read More

Italy’s Menarini to acquire US biopharma company Stemline Therapeutics

pharmanewsdaily- May 5, 2020

Menarini acquisition of Stemline : Menarini Group, an Italian pharma and diagnostics company, has agreed to acquire US biopharma company Stemline Therapeutics in a deal ... Read More